EyePoint Pharmaceuticals

SEC Filing Details

Document Details

Form
Filing Date
Apr 16, 2019
Document Date
Apr 12, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EyePoint Pharmaceuticals, Inc.
Filer
Duker Jay S.
EyePoint Pharmaceuticals